Bio-Rad Laboratories PE Ratio 2006-2019 | BIO

Current and historical p/e ratio for Bio-Rad Laboratories (BIO) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Bio-Rad Laboratories PE ratio as of August 16, 2019 is 50.45.
Bio-Rad Laboratories PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-08-16 327.50 11.06
2019-06-30 312.59 $29.61 10.56
2019-03-31 305.68 $18.62 16.42
2018-12-31 232.22 $11.65 19.93
2018-09-30 312.99 $41.85 7.48
2018-06-30 288.54 $33.87 8.52
2018-03-31 250.08 $25.17 9.94
2017-12-31 238.67 $3.81 62.64
2017-09-30 222.22 $0.79 281.29
2017-06-30 226.31 $0.50 452.62
2017-03-31 199.34 $0.94 212.06
2016-12-31 182.28 $0.95 191.87
2016-09-30 163.81 $3.33 49.19
2016-06-30 143.02 $3.30 43.34
2016-03-31 136.72 $3.66 37.36
2015-12-31 138.66 $3.85 36.02
2015-09-30 134.31 $3.51 38.26
2015-06-30 150.61 $3.31 45.50
2015-03-31 135.18 $3.43 39.41
2014-12-31 120.56 $3.05 39.53
2014-09-30 113.40 $2.75 41.24
2014-06-30 119.71 $2.11 56.73
2014-03-31 128.12 $2.22 57.71
2013-12-31 123.61 $2.67 46.30
2013-09-30 117.56 $3.28 35.84
2013-06-30 112.20 $5.01 22.40
2013-03-31 126.00 $5.50 22.91
2012-12-31 105.05 $5.91 17.77
2012-09-30 106.72 $6.34 16.83
2012-06-30 100.01 $6.47 15.46
2012-03-31 103.69 $6.19 16.75
2011-12-31 96.04 $6.26 15.34
2011-09-30 90.77 $6.59 13.77
2011-06-30 119.36 $6.57 18.17
2011-03-31 120.14 $6.51 18.45
2010-12-31 103.85 $6.59 15.76
2010-09-30 90.51 $5.53 16.37
2010-06-30 86.49 $5.32 16.26
2010-03-31 103.52 $5.34 19.39
2009-12-31 96.46 $5.20 18.55
2009-09-30 91.88 $3.55 25.88
2009-06-30 75.48 $3.18 23.74
2009-03-31 65.90 $3.39 19.44
2008-12-31 75.31 $3.25 23.17
2008-09-30 99.12 $4.00 24.78
2008-06-30 80.89 $4.02 20.12
2008-03-31 88.95 $3.39 26.24
2007-12-31 103.62 $3.42 30.30
2007-09-30 90.50 $3.58 25.28
2007-06-30 75.57 $3.41 22.16
2007-03-31 69.84 $3.66 19.08
2006-12-31 82.52 $3.83 21.55
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $9.411B $2.290B
Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials, and to identify, analyze, and purify their components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment offers electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation, and amplification products and services. The Clinical Diagnostics segment provides control, autoimmune, diabetes, and blood virus testing products. Bio-Rad is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. The company is headquartered in Hercules, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.355B 27.89
Medtronic (MDT) Ireland $135.363B 19.33
Stryker (SYK) United States $79.332B 27.43
Boston Scientific (BSX) United States $57.711B 27.99
Baxter (BAX) United States $43.826B 26.58
EssilorLuxottica Societe Anonyme (ESLOY) France $30.982B 0.00
Zimmer Biomet Holdings (ZBH) United States $27.498B 17.60
Coloplast (CLPBY) Denmark $25.855B 41.28
Lonza Group Ag (LZAGY) Switzerland $25.781B 0.00
Terumo (TRUMY) Japan $24.206B 27.83
Smith & Nephew SNATS (SNN) United Kingdom $19.922B 0.00
ResMed (RMD) United States $18.842B 35.93
Sunny Optical Technology (SNPTF) China $12.767B 0.00
Canopy Growth (CGC) Canada $11.069B 0.00
Insulet (PODD) United States $8.823B 522.82
William Demant Holdings (WILYY) Denmark $7.136B 0.00
Hill-Rom Holdings (HRC) United States $7.008B 20.89
Haemonetics (HAE) United States $6.844B 51.65
Perrigo (PRGO) Ireland $6.367B 11.73
Aurora Cannabis (ACB) Canada $6.196B 60.90
GN STORE NORD (GNNDY) Denmark $5.897B 30.11
GW Pharmaceuticals (GWPH) United Kingdom $4.679B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $3.579B 59.53
ICU Medical (ICUI) United States $3.404B 22.08
NuVasive (NUVA) United States $3.312B 26.40
Quidel (QDEL) United States $2.659B 26.41
Hutchison China MediTech (HCM) China $2.621B 0.00
Agios Pharmaceuticals (AGIO) United States $2.526B 0.00
National Vision Holdings (EYE) United States $2.259B 48.76
Cardiovascular Systems (CSII) United States $1.623B 0.00
Aphria (APHA) $1.604B 0.00
Phibro Animal Health (PAHC) United States $1.216B 18.22
AtriCure (ATRC) United States $1.080B 0.00
VAREX IMAGING (VREX) United States $0.990B 22.81
Omeros (OMER) United States $0.942B 0.00
NanoString Technologies (NSTG) United States $0.940B 0.00
PetIQ (PETQ) United States $0.908B 21.44
Lantheus Holdings (LNTH) United States $0.827B 21.74
Eagle Pharmaceuticals (EGRX) United States $0.768B 19.58
Cerus (CERS) United States $0.732B 0.00
MacroGenics (MGNX) United States $0.729B 0.00
TG Therapeutics (TGTX) United States $0.655B 0.00
Quanterix (QTRX) United States $0.651B 0.00
LeMaitre Vascular (LMAT) United States $0.627B 37.14
Surmodics (SRDX) United States $0.591B 112.36
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.446B 0.00
OraSure Technologies (OSUR) United States $0.444B 20.54
Meridian Bioscience (VIVO) United States $0.437B 13.64
Utah Medical Products (UTMD) United States $0.357B 26.16
BioLife Solutions (BLFS) United States $0.338B 111.31
United Health Products (UEEC) United States $0.321B 0.00
Owens & Minor (OMI) United States $0.299B 8.96
Zynex (ZYXI) United States $0.297B 31.59
Bovie Medical (APYX) United States $0.258B 0.00
Vapotherm (VAPO) United States $0.253B 0.00
Chimerix (CMRX) United States $0.165B 0.00
Cytosorbents (CTSO) United States $0.164B 0.00
Rockwell Medical (RMTI) United States $0.158B 0.00
Fonar (FONR) United States $0.150B 7.89
Female Health (VERU) United States $0.125B 0.00
Chembio Diagnostics (CEMI) United States $0.101B 0.00
InfuSystems Holdings (INFU) United States $0.095B 0.00
United-Guardian (UG) United States $0.087B 20.60
Oramed Pharmaceuticals (ORMP) United States $0.058B 0.00
Surface Oncology (SURF) United States $0.056B 0.00
MRI INTERVENTNS (MRIC) United States $0.048B 0.00
Trinity Biotech (TRIB) Ireland $0.042B 14.58
ImmuCell (ICCC) United States $0.041B 0.00
Senestech (SNES) United States $0.035B 0.00
Valeritas Holdings (VLRX) United States $0.012B 0.00
Myomo (MYO) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Akers Biosciences Inc (AKER) United States $0.007B 0.00
GUARDION HEALTH (GHSI) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00
Nephros (NEPH) United States $0.000B 0.00